Safety and clinical efficacy of rapidly-generated virus-specific T cells with activity against adv, EBV, CMV, HHV6 and BK virus administered after allogeneic hematopoietic stem cell transplant
2014 ◽
Vol 20
(2)
◽
pp. S48
◽
2013 ◽
Vol 19
(2)
◽
pp. S111
2011 ◽
Vol 17
(2)
◽
pp. S282-S283
2009 ◽
Vol 45
(3)
◽
pp. 543-549
◽
2019 ◽
Vol 25
(3)
◽
pp. S359-S360